mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
1e-22 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
2e-20 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
2e-18 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
3e-17 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
3e-17 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
1e-14 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-14 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-14 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-14 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-14 |